A Win For Hoth Therapeutics, Inc.

Thu, Dec 15, 2022 at 06:58 PM
A Win For Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc. (HOTH:NASDAQ) soared at $4.17, a gain of 31.1%. On Thu, Dec 15, 2022, HOTH:NASDAQ hit a New 2-Week High of $4.17. The stock appeared on our News Catalysts scanner on Thu, Dec 01, 2022 at 11:32 AM in the 'INVESTOR UPDATE' category. From Thu, Dec 01, 2022, the stock recorded 30.00% Up Days and 9.09% Green Days

About Hoth Therapeutics, Inc. (HOTH:NASDAQ)

Hoth Therapeutics Inc is a development stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.